STOCK TITAN

Cencora (COR) CEO exercises options and sells 3,762 common shares

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Cencora, Inc. President & CEO Robert P. Mauch exercised and sold company stock in related moves. He exercised a non-qualified stock option for 3,762 shares on February 20, 2026 at an exercise price of $86.09 per share, receiving common stock. On the same day, he sold 3,762 common shares in an open-market transaction at an average price of $358.94 per share. Following these transactions, his directly held common stock position was 65,393 shares. The option had become exercisable in four equal installments on November 13, 2020, 2021, 2022, and 2023.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mauch Robert P.

(Last) (First) (Middle)
1 WEST FIRST AVENUE

(Street)
CONSHOHOCKEN PA 19428

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cencora, Inc. [ COR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President & CEO
3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/20/2026 M 3,762 A $86.09 69,155 D
Common Stock 02/20/2026 S 3,762 D $358.94 65,393 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-qualified Stock Option (Right to Buy) $86.09 02/20/2026 M 3,762 (1) 11/13/2026 Common Stock 3,762 $0 0 D
Explanation of Responses:
1. Exercisable in four equal installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23.
Remarks:
/s/ Elizabeth S. Campbell, attorney-in-fact for Robert P. Mauch 02/24/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Cencora (COR) CEO Robert Mauch report?

Robert Mauch exercised a non-qualified stock option for 3,762 shares and sold 3,762 common shares of Cencora, Inc. on February 20, 2026. The sale was an open-market transaction at an average price of $358.94 per share.

How many Cencora (COR) shares did the CEO sell and at what price?

Robert Mauch sold 3,762 common shares of Cencora at an average price of $358.94 per share. The sale occurred on February 20, 2026 and was reported as an open-market or private transaction under code "S."

What stock option did the Cencora (COR) CEO exercise in this Form 4?

He exercised a non-qualified stock option covering 3,762 shares at an exercise price of $86.09 per share. The option became exercisable in four equal installments on November 13, 2020, 2021, 2022, and 2023.

What is Robert Mauch’s Cencora (COR) share ownership after these trades?

After the reported transactions, Robert Mauch directly owned 65,393 shares of Cencora common stock. This figure reflects his holdings following the exercise of options and the same-day sale of 3,762 common shares reported in the filing.

Were Cencora (COR) CEO Robert Mauch’s transactions open-market sales or option exercises?

The Form 4 shows both an option exercise and an open-market sale. He exercised a non-qualified stock option for 3,762 shares and then sold 3,762 common shares, coded "M" for exercise and "S" for sale, respectively.
Cencora Inc.

NYSE:COR

COR Rankings

COR Latest News

COR Latest SEC Filings

COR Stock Data

71.32B
186.29M
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
CONSHOHOCKEN